IRD vs REG · rev $11.0M vs P/E 34, $12.93B cap
Opus Genetics, Inc. (IRD) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
REG does not have a complete income-statement cache yet.
IRD currently screens at market cap $35.7M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the IRD and REG stock pages for the full models.
Not investment advice.